ArticleJournal of ophthalmology2022

Netarsudil as an Adjunctive Therapy: Efficacy and Factors Contributing to a Favorable IOP-Lowering Effect.

Sandy Samuel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.